The Interaction of Heptakis (2,6-di-O-Methyl)-β-cyclodextrin with Mianserin Hydrochloride and Its Influence on the Drug Toxicity

被引:4
|
作者
Belica-Pacha, Sylwia [1 ]
Malecka, Magdalena [1 ]
Dasko, Mateusz [2 ]
Milowska, Katarzyna [3 ]
Bryszewska, Maria [3 ]
Budryn, Grazyna [4 ]
Oracz, Joanna [4 ]
Palecz, Bartlomiej [1 ]
机构
[1] Univ Lodz, Fac Chem, Dept Phys Chem, Unit Biophys Chem, Pomorska 165, PL-90236 Lodz, Poland
[2] Gdansk Univ Technol, Fac Chem, Dept Inorgan Chem, Narutowicza 11-12, PL-80233 Gdansk, Poland
[3] Univ Lodz, Fac Biol & Environm Protect, Dept Gen Biophys, Pomorska 141-143, PL-90236 Lodz, Poland
[4] Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Food Technol & Anal, Stefanowskiego 4-10, PL-90924 Lodz, Poland
关键词
mianserin hydrochloride; heptakis (2,6-di-O-methyl)-beta-cyclodextrin; isothermal titration calorimetry; circular dichroism; mass spectrometry; molecular docking; cytotoxicity; INDUCED CIRCULAR-DICHROISM; CYCLODEXTRIN INCLUSION COMPLEXES; ISOTHERMAL TITRATION CALORIMETRY; BETA-CYCLODEXTRIN; MOLECULAR RECOGNITION; GENERAL RULE; BINDING; GUEST; CRYSTAL; DIFFERENTIATION;
D O I
10.3390/ijms22179419
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
One tetracyclic antidepressant, mianserin hydrochloride (MIA), has quite significant side effects on a patients' health. Cyclodextrins, which are most commonly used to reduce the undesirable features of contained drugs within their hydrophobic interior, also have the potential to alter the toxic behavior of the drug. The present paper contains investigations and the characteristics of interaction mechanisms for MIA and the heptakis (2,6-di-O-methyl)-beta-cyclodextrin (DM-beta-CD) system, and evaluated the effects of the complexation on MIA cytotoxicity. In order to assess whether there was an interaction between MIA and DM-beta-CD molecules, isothermal titration calorimetry (ITC) have been chosen. Electrospray ionization mass spectrometry (ESI-MS) helped to establish the complex stoichiometry, and circular dichroism spectroscopy was used to describe the process of complex formation. In order to make a wider interpretative perspective, the molecular docking results have been performed. The viability of Chinese hamster cells were investigated in the presence of DM-beta-CD and its complexes with MIA in order to estimate the cytotoxicity of the drug and the conjugate with the chosen cyclodextrin. The viability of B14 cells treated with MIA+DM-beta-CD is lower (the toxicity is higher) than with MIA alone, and no protective effects have been observed for complexes of MIA with DM-beta-CD in any ratio.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] HEPTAKIS(2,6-DI-O-METHYL)-BETA-CYCLODEXTRIN COMPLEXATION, WITH GLUTETHIMIDE
    ELGENDY, GA
    ELGENDY, MA
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1993, 39 (06) : 249 - 254
  • [2] Inclusion phenomena of clove oil with α-, β-, γ- and heptakis (2,6-di-O-methyl)-β-cyclodextrin
    Song, L. X.
    Xu, P.
    Wang, H. M.
    Yang, Y.
    [J]. NATURAL PRODUCT RESEARCH, 2009, 23 (09) : 789 - 800
  • [3] Encapsulation of 6-hydroxyquinoline in heptakis(2,6-di-O-methyl)-β-cyclodextrin
    Lee, Young-Shin
    Park, Han Jung
    Jang, Du-Jeon
    [J]. BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2006, 27 (09) : 1450 - 1452
  • [4] Inclusion interaction of chloramphenicol and heptakis (2,6-di-O-methyl)-β-cyclodextrin: Phase solubility and spectroscopic methods
    Shi, Jie-Hua
    Zhou, Ya-fang
    [J]. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2011, 83 (01) : 570 - 574
  • [5] Calorimetric and spectroscopic characterization of complexes between β-cyclodextrin or heptakis (2,6-di-O-methyl)-β-cyclodextrin and sertraline hydrochloride in aqueous solution
    Belica, S.
    Jeziorska, D.
    Urbaniak, P.
    Buko, V. U.
    Zavodnik, I. B.
    Palecz, B.
    [J]. JOURNAL OF CHEMICAL THERMODYNAMICS, 2014, 70 : 160 - 167
  • [6] The Heptakis-(2,6-di-O-methyl)-β-cyclodextrin inclusion complex with acetic acid
    ER5128-CNRS, Centre Pharmaceutique, Université Paris-Sud, 92296 Chátenay-Malabry, France
    不详
    [J]. J. Incl. Phenom., 1 (1-12):
  • [7] The Heptakis-(2,6-di-O-methyl)-β-cyclodextrin Inclusion Complex with Acetic Acid
    M. Selkti
    A. Navaza
    F. Villain
    P. Charpin
    C. De Rango
    [J]. Journal of inclusion phenomena and molecular recognition in chemistry, 1997, 27 : 1 - 12
  • [8] Formation, characterization and pH dependence of rifampicin: heptakis( 2,6-di-O-methyl)-β-cyclodextrin complexes
    Angiolini, Lorenzo
    Agnes, Marco
    Cohen, Boiko
    Yannakopoulou, Konstantina
    Douhal, Abderrazzak
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 531 (02) : 668 - 675
  • [9] HEPTAKIS(2,6-DI-O-METHYL)-BETA-CYCLODEXTRIN COMPLEXATION WITH THE ANTITUMOR AGENT CHLORAMBUCIL
    GREEN, AR
    GUILLORY, JK
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (05) : 427 - 431
  • [10] Chiral separation of reduced haloperidol by capillary zone electrophoresis with heptakis (2,6-Di-o-methyl)-β-cyclodextrin
    Wu, H.L.
    Otsuka, K.
    Terabe, S.
    [J]. Journal of Liquid Chromatography & Related Technologies, 1996, 19 (10):